Pomerantz files class action against Nano-X Imaging alleging securities fraud tied to manufacturing risks and financial disclosures

Executive summary: Pomerantz LLP filed a class action lawsuit against Nano-X Imaging Ltd. and certain officers alleging securities fraud related to misleading disclosures about manufacturing risks and financial performance. The lawsuit highlights ongoing investor concerns about transparency in Nano-X’s financial reporting and operational execution, potentially exposing the company to legal costs, settlements, and reputational harm.

Who is involved: Pomerantz LLP (plaintiffs' counsel), Nano-X Imaging Ltd., its officers, and investors who purchased NNOX securities between March 31, 2025 and April 17, 2026.

Likely next: Court proceedings will determine class certification; lead plaintiff selection is expected by August 11, 2026, with potential settlement or litigation to follow.

On August 6, 2026, Pomerantz LLP announced the filing of a class action lawsuit against Nano-X Imaging Ltd. (NASDAQ: NNOX) and certain officers in the United States District Court for the District of New York. The lawsuit claims that the company made false or misleading statements regarding its manufacturing capabilities and financial performance, allegedly omitting known risks related to cash burn and production challenges. Investors who purchased Nano-X securities between March 31, 2025 and April 17, 2026 are included in the proposed class period. The filing follows a series of investor alerts and warnings from multiple law firms about potential losses tied to a 24.39% stock decline after disclosed impairments and restructuring.

Timeline

2026-08-06 — Pomerantz Law Firm Announces the Filing of a Class Action Against Nano-X Imaging Ltd. and Certain Officers - NNOX (PR Newswire)
2026-08-06 — SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2026 in Nano-X Imaging Ltd. Lawsuit - NNOX (PR Newswire)
2026-08-05 — Levi & Korsinsky Reminds Nano-X Imaging Ltd. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 11, 2026 - NNOX (PR Newswire)
2026-08-05 — Nano-X Imaging Ltd. Stockholders Who Suffered Significant Losses Should Contact Robbins LLP Before the August 11 Lead Plaintiff Deadline for Information About Their Rights Against NNOX (PR Newswire)
2026-08-05 — NNOX Deadline: NNOX Investors Have Opportunity to Lead Nano-X Imaging Ltd. Securities Fraud Lawsuit (PR Newswire)
2026-08-04 — The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2026 in Nano-X Imaging Ltd. Lawsuit - NNOX (PR Newswire)

Analysis — what this means

Likely next events

Lead plaintiff deadline: August 11, 2026
Potential class certification hearing: Q4 2026

Sectors affected

Medical imaging equipment
Healthcare technology
Nasdaq-listed medical device firms

Regulatory implications

Possible SEC scrutiny over prior disclosures related to Q4 2025 net loss and manufacturing risks
Increased focus on internal controls under SOX for medical device firms
PSLRA governs lead plaintiff selection and pleading standards

Historical parallels

Theranos securities litigation (2018) over misleading blood test technology claims
GE Healthcare accounting review (2021) involving prior period financial adjustments
Fujifilm Holdings shareholder suit (2020) over diagnostic imaging business disclosures